Gerresheimer AG (ETR:GXI)
42.00
-1.38 (-3.18%)
Aug 1, 2025, 5:35 PM CET
Gerresheimer AG Revenue
Gerresheimer AG had revenue of 600.66M EUR in the quarter ending May 31, 2025, with 19.56% growth. This brings the company's revenue in the last twelve months to 2.19B, up 9.32% year-over-year. In the fiscal year ending November 30, 2024, Gerresheimer AG had annual revenue of 2.04B with 2.28% growth.
Revenue (ttm)
2.19B
Revenue Growth
+9.32%
P/S Ratio
0.66
Revenue / Employee
160.70K
Employees
12,142
Market Cap
1.45B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 2.04B | 45.42M | 2.28% |
Nov 30, 2023 | 1.99B | 173.39M | 9.54% |
Nov 30, 2022 | 1.82B | 319.09M | 21.30% |
Nov 30, 2021 | 1.50B | 79.22M | 5.58% |
Nov 30, 2020 | 1.42B | 26.53M | 1.91% |
Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Gerresheimer AG News
- 16 days ago - Gerresheimer calls a halt to discussions on potential takeover - Reuters
- 16 days ago - Gerresheimer Halts Takeover Talks: No Deal with Private Equity - Wallstreet:Online
- 16 days ago - EQS-News: Gerresheimer ends discussions with private equity investors about a potential takeover offer - Wallstreet:Online
- 16 days ago - EQS-Adhoc: Gerresheimer AG: Discussions on potential takeover offer ended - Wallstreet:Online
- 18 days ago - EQS-News: Gerresheimer Achieves A- Score in CDP Rating - Wallstreet:Online
- 23 days ago - Gerresheimer cuts its 2025 revenue outlook for second time - Reuters
- 23 days ago - Gerresheimer H1 2025: Bormioli Pharma Drives Revenue Surge - Wallstreet:Online
- 23 days ago - EQS-News: Gerresheimer in H1 2025: Bormioli Pharma boosts revenues and earnings, continued market influences in operating business - Wallstreet:Online